Salivary gland tumours are one of the most difficult areas of diagnostic pathology, with
significant morphological diversity and many overlapping features. The latest WHO …

Background Mammary analog secretory carcinoma of the salivary glands (MASCSG) is a
newly introduced malignant tumor of the salivary glands. For decades, it has been confused …

Objective The aim of this systematic review was to describe the epidemiology, diagnostic
criteria, differential diagnosis, treatment, prognostic factors, and treatment outcomes of …

Salivary gland cytology is challenging, and historically the role of ancillary testing has been
limited. However, numerous molecular/genetic advances in the understanding of salivary …

Aims Secretory carcinoma (SC)(synonym: mammary analogue secretory carcinoma) is a low‐
grade salivary gland tumour that occurs in both major and minor salivary glands. SC is …

DOG1 is an established diagnostic marker for gastrointestinal stromal tumours (GIST), but
has been reported in salivary gland tumours (SGT) as an acinar and intercalated duct …

Mammary analogue secretory carcinoma (MASC) is a recently discovered salivary gland
tumor described mostly in the major salivary glands and occasionally in the skin. We report a …

Objectives Secretory Carcinoma is a malignant salivary gland tumor, initially described in
2010. This rare tumor is associated with the translocation t (12; 15)(p13; q25), resulting in …

Background Low-grade intraductal carcinomas are rare, malign tumors of salivary glands
most commonly affecting parotid gland. It is a slow-growing tumor considered with a …

Mucoepidermoid carcinoma (MEC) is one of the most frequently misdiagnosed tumors.
Glycans are modulated by malignant transformation. Mucin 1 (MUC1) is a mucin whose …